In this review, we describe major evidence for naturally occurring PD-1/PD-L1 signaling to fine modulate GC reactions and discuss evidences for how GC-derived malignant cells may exploit this immune-checkpoint to facilitate selection and survival first, and elude anti-tumour immune responses later at advanced DLBCL stages. Here, CD274 is linked to diffuse large B-cell lymphoma.